Huang Z, Zhu T, Chen X, Piao M, et al. Postoperative adjuvant TACE combined with lenvatinib and immune checkpoint inhibitors for hepatocellular carcinoma with high recurrence risks: a multicenter retrospective study. BMC Cancer 2026 Jan 20. doi: 10.1186/s12885-026-15586.
PMID: 41559685